| PAGANO, Livio, Jon SALMANTON-GARCÍA, Francesco MARCHESI, Alberto LÓPEZ-GARCÍA, Sylvain LAMURE, Federico ITRI, Maria GOMES-SILVA, Giulia DRAGONETTI, Iker FALCES-ROMERO, Jaap van DOESUM, Uluhan SILI, Jorge LABRADOR, Maria CALBACHO, Yavuz M BILGIN, Barbora WEINBERGEROVÁ, Laura SERRANO, José-María Ribera-Santa SUSANA, Sandra MALAK, José LOUREIRO-AMIGO, Andreas GLENTHØJ, Raúl CÓRDOBA-MASCUÑANO, Raquel NUNES-RODRIGUES, Tomás-José GONZÁLEZ-LÓPEZ, Linda Katharina KARLSSON, María-Josefa JIMÉNEZ-LORENZO, José-Ángel HERNÁNDEZ-RIVAS, Ozren JAKSIC, Zdeněk RÁČIL, Alessandro BUSCA, Paolo CORRADINI, Martin HOENIGL, Nikolai KLIMKO, Philipp KOEHLER, Antonio PAGLIUCA, Francesco PASSAMONTI and Oliver A CORNELY. COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA. Blood. Washington DC, USA: American Society of Hematology, 2022, vol. 139, No 10, p. 1588-1592. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2021014124. |
Other formats:
BibTeX
LaTeX
RIS
@article{1853630,
author = {Pagano, Livio and SalmantonandGarcía, Jon and Marchesi, Francesco and LópezandGarcía, Alberto and Lamure, Sylvain and Itri, Federico and GomesandSilva, Maria and Dragonetti, Giulia and FalcesandRomero, Iker and Doesum, Jaap van and Sili, Uluhan and Labrador, Jorge and Calbacho, Maria and Bilgin, Yavuz M and Weinbergerová, Barbora and Serrano, Laura and Susana, JoséandMaría RiberaandSanta and Malak, Sandra and LoureiroandAmigo, José and Glenthøj, Andreas and CórdobaandMascuñano, Raúl and NunesandRodrigues, Raquel and GonzálezandLópez, TomásandJosé and Karlsson, Linda Katharina and JiménezandLorenzo, MaríaandJosefa and HernándezandRivas, JoséandÁngel and Jaksic, Ozren and Ráčil, Zdeněk and Busca, Alessandro and Corradini, Paolo and Hoenigl, Martin and Klimko, Nikolai and Koehler, Philipp and Pagliuca, Antonio and Passamonti, Francesco and Cornely, Oliver A},
article_location = {Washington DC, USA},
article_number = {10},
doi = {http://dx.doi.org/10.1182/blood.2021014124},
keywords = {COVID-19; patients with hematological malignancies; vaccination; EPICOVIDEHA},
language = {eng},
issn = {0006-4971},
journal = {Blood},
title = {COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA},
url = {https://ashpublications.org/blood/article/139/10/1588/477881/COVID-19-in-vaccinated-adult-patients-with},
volume = {139},
year = {2022}
}
TY - JOUR
ID - 1853630
AU - Pagano, Livio - Salmanton-García, Jon - Marchesi, Francesco - López-García, Alberto - Lamure, Sylvain - Itri, Federico - Gomes-Silva, Maria - Dragonetti, Giulia - Falces-Romero, Iker - Doesum, Jaap van - Sili, Uluhan - Labrador, Jorge - Calbacho, Maria - Bilgin, Yavuz M - Weinbergerová, Barbora - Serrano, Laura - Susana, José-María Ribera-Santa - Malak, Sandra - Loureiro-Amigo, José - Glenthøj, Andreas - Córdoba-Mascuñano, Raúl - Nunes-Rodrigues, Raquel - González-López, Tomás-José - Karlsson, Linda Katharina - Jiménez-Lorenzo, María-Josefa - Hernández-Rivas, José-Ángel - Jaksic, Ozren - Ráčil, Zdeněk - Busca, Alessandro - Corradini, Paolo - Hoenigl, Martin - Klimko, Nikolai - Koehler, Philipp - Pagliuca, Antonio - Passamonti, Francesco - Cornely, Oliver A
PY - 2022
TI - COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
JF - Blood
VL - 139
IS - 10
SP - 1588-1592
EP - 1588-1592
PB - American Society of Hematology
SN - 00064971
KW - COVID-19
KW - patients with hematological malignancies
KW - vaccination
KW - EPICOVIDEHA
UR - https://ashpublications.org/blood/article/139/10/1588/477881/COVID-19-in-vaccinated-adult-patients-with
N2 - Coronavirus disease 2019 (COVID-19) is a life-threatening condition of high relevance for comorbid patients, such as those with baseline hematological malignancies (HM). In April 2020, the European Hematology Association - Infectious Diseases Working Party opened an open web-based registry to collect all cases of HM adult patients that developed COVID-19 infections (EPICOVIDEHA survey). This registry aimed to describe the epidemiology, risk factors, and mortality rates of HM patients. Overall, we collected 3801 valid cases, and we observed an overall mortality rate of 31%.
ER -
PAGANO, Livio, Jon SALMANTON-GARCÍA, Francesco MARCHESI, Alberto LÓPEZ-GARCÍA, Sylvain LAMURE, Federico ITRI, Maria GOMES-SILVA, Giulia DRAGONETTI, Iker FALCES-ROMERO, Jaap van DOESUM, Uluhan SILI, Jorge LABRADOR, Maria CALBACHO, Yavuz M BILGIN, Barbora WEINBERGEROVÁ, Laura SERRANO, José-María Ribera-Santa SUSANA, Sandra MALAK, José LOUREIRO-AMIGO, Andreas GLENTHØJ, Raúl CÓRDOBA-MASCUÑANO, Raquel NUNES-RODRIGUES, Tomás-José GONZÁLEZ-LÓPEZ, Linda Katharina KARLSSON, María-Josefa JIMÉNEZ-LORENZO, José-Ángel HERNÁNDEZ-RIVAS, Ozren JAKSIC, Zdeněk RÁČIL, Alessandro BUSCA, Paolo CORRADINI, Martin HOENIGL, Nikolai KLIMKO, Philipp KOEHLER, Antonio PAGLIUCA, Francesco PASSAMONTI and Oliver A CORNELY. COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA. \textit{Blood}. Washington DC, USA: American Society of Hematology, 2022, vol.~139, No~10, p.~1588-1592. ISSN~0006-4971. Available from: https://dx.doi.org/10.1182/blood.2021014124.
|
